儿童研究中基因组检测的伦理与政策考量:迈向披露个体研究结果的路径
DNA在临床研究中常被采集用于即时基因组分析或储存备用,许多基因组研究设计时未预见结果披露的伦理问题。2004年启动的CKiD队列研究未预见基因组技术及相关伦理问题,近期研究促使研究者重新评估基因组检测与结果披露的伦理政策环境。本文探讨下一代测序与个体结果披露议题,以指导当前和未来研究实践。
要点
- 儿童基因组研究设计需前瞻考虑结果披露的伦理问题
- CKiD队列研究经验提示需重新评估伦理政策环境
- 下一代测序的个体结果披露应指导未来研究实践
核心结论
- 儿童基因组研究需重新评估伦理与政策环境以指导个体结果披露实践。
研究设计与样本
- 本文为CKiD队列研究研究者基于近期基因组研究及附属提案对伦理政策环境的评述。
主要发现
- 2004年CKiD启动时未预见基因组技术发展及相关伦理问题。
- 近期基因组研究促使研究者重新评估基因组检测与结果披露的伦理政策环境。
临床怎么用
- 儿童基因组研究应前瞻考虑个体结果披露的伦理与政策问题。
- 下一代测序相关研究需借鉴CKiD经验以指导实践。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
DNA is now commonly collected in clinical research either for immediate genomic analyses or stored for future studies. Many genomic studies were previously designed without awareness of the ethical issues that might arise regarding the disclosure of genomic test results. At the start of the Chronic Kidney Disease in Children (CKiD) Cohort Study in 2004, we did not foresee the advent of genomic technology or the associated ethical issues pertaining to genetic research in children. Recent genomic studies and ancillary proposals using genomic technology stimulated the CKiD investigators to reassess the current ethical and policy environment pertaining to genomic testing and results disclosure. We consider the issues pertaining to next generation sequencing and individual results disclosure that may guide current and future research practices.
引用
- Wong CS, Kogon AJ, Warady BA, et al. Ethical and Policy Considerations for Genomic Testing in Pediatric Research: The Path Toward Disclosing Individual Research Results. Am J Kidney Dis. 2019. PMID: 30879919. doi:10.1053/j.ajkd.2019.01.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。